Myofilament dysfunction in cardiac disease from mice to men
In healthy human myocardium a tight balance exists between receptor-mediated kinases and phosphatases coordinating phosphorylation of regulatory proteins involved in cardiomyocyte contractility. During heart failure, when neurohumoral stimulation increases to compensate for reduced cardiac pump function, this balance is perturbed. The imbalance between kinases and phosphatases upon chronic neurohumoral stimulation is detrimental and initiates cardiac remodelling, and phosphorylation changes of regulatory proteins, which impair cardiomyocyte function. The main signalling pathway involved in enhanced cardiomyocyte contractility during increased cardiac load is the β-adrenergic signalling route, which becomes desensitized upon chronic stimulation. At the myofilament level, activation of protein kinase A (PKA), the down-stream kinase of the β-adrenergic receptors (β-AR), phosphorylates troponin I, myosin binding protein C and titin, which all exert differential effects on myofilament function. As a consequence of β-AR down-regulation and desensitization, phosphorylation of the PKA-target proteins within the cardiomyocyte may be decreased and alter myofilament function. Here we discuss involvement of altered PKA-mediated myofilament protein phosphorylation in different animal and human studies, and discuss the roles of troponin I, myosin binding protein C and titin in regulating myofilament dysfunction in cardiac disease. Data from the different animal and human studies emphasize the importance of careful biopsy procurement, and the need to investigate localization of kinases and phosphatases within the cardiomyocyte, in particular their co-localization with cardiac myofilaments upon receptor stimulation.
|Keywords||Heart failure, Kinase, Myofilament function, Phosphatase, Phosphorylation, Protein kinase A, adrenergic signalling, animal experiment, animal model, beta adrenergic receptor, connectin, controlled study, cyclic AMP dependent protein kinase, heart disease, heart failure, heart muscle cell, human, male, muscle force, muscle stiffness, myofilament, myosin binding protein C, nonhuman, priority journal, protein function, protein localization, protein phosphorylation, review, signal transduction, troponin I|
|Persistent URL||dx.doi.org/10.1007/s10974-008-9160-y, hdl.handle.net/1765/18118|
Hamdani, N, de Waard, M.C, Messer, A.E, Boontje, N.M, Kooij, V, van Dijk, S.J, … van der Velden, J. (2008). Myofilament dysfunction in cardiac disease from mice to men. Journal of Muscle Research and Cell Motility, 29(6-8), 189–201. doi:10.1007/s10974-008-9160-y